Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C3E0 | ISIN: KYG3871A1004 | Ticker-Symbol: 67N0
Tradegate
05.06.25 | 15:23
0,306 Euro
+7,75 % +0,022
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
GENOR BIOPHARMA HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
GENOR BIOPHARMA HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,2540,32606.06.
0,2640,30206.06.

Aktuelle News zur GENOR BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.05.GENOR-B (06998): VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED NEW DRUG APPLICATION APPROVAL FOR LEROCICLIB (GB491)4
27.05.GENOR-B (06998): NEXT DAY DISCLOSURE RETURN1
26.05.GENOR-B (06998): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 501-02, 5/F, BUILDING 6, 690 BIBO ROAD, PUDONG NEW DISTRICT, SHANGHAI, ...-
26.05.GENOR-B (06998): (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; (3) ...-
26.05.GENOR-B (06998): NOTICE OF ANNUAL GENERAL MEETING1
15.05.GENOR-B (06998): MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER ...1
24.04.GENOR-B (06998): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT-
GENOR BIOPHARMA Aktie jetzt für 0€ handeln
24.04.GENOR-B (06998): 2024 ANNUAL REPORT-
17.04.GENOR-B (06998): CONNECTED TRANSACTION2
15.04.GENOR-B (06998): FILING OF THE NEW LISTING APPLICATION2
24.03.GENOR-B (06998): MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER ...3
18.03.GENOR-B (06998): DATE OF BOARD MEETING-
25.02.GENOR-B (06998): MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER ...1
19.02.GENOR-B (06998): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 19 FEBRUARY 2025-
03.02.GENOR-B (06998): NOTICE OF EXTRAORDINARY GENERAL MEETING2
03.02.GENOR-B (06998): FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD AT ROOM 501-02, BUILDING 6, 690 BIBO ROAD, PUDONG NEW DISTRICT, SHANGHAI, ...2
03.02.GENOR-B (06998): PROPOSED REMOVAL AND APPOINTMENT OF AUDITOR AND NOTICE OF EXTRAORDINARY GENERAL MEETING1
03.02.GENOR-B (06998): POSTPONEMENT OF EXTRAORDINARY GENERAL MEETING AND CHANGE OF BOOK CLOSURE PERIOD1
24.01.GENOR-B (06998): MONTHLY UPDATE ON (1) VERY SUBSTANTIAL ACQUISITION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER ...-
23.01.GENOR-B (06998): CLOSURE OF REGISTER OF MEMBERS1
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1